Synthesis of condensed quinolines and quinazolines as DNA ligands

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 3, 2004, Pages 641-647

  Malecki, Natacha ^a   Carato, Pascal ^a   Rigo, Benoît ^b   Goossens, Jean François ^a   Houssin, Raymond ^a   Bailly, Christian ^c   Hénichart, Jean Pierre ^a  

^a UNIV LILLE   (France)

^b Ecole des Hautes Etudes d'Ingenieur   (France)

^c INSERM   (France)

Author keywords

DNA ligands; Quinazolines; Quinolines

Indexed keywords

8 METHOXY 7 PIPERAZINYLPROPOXYINDENO[1,2 B]QUINOLIN 11 ONE; ALKALOID; BATRACYLIN; CAMPTOTHECIN; LIGAND; PIPERAZINE DERIVATIVE; QUINAZOLINE DERIVATIVE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DNA BINDING; DRUG DESIGN; DRUG STRUCTURE; POLYMERIZATION; SYNTHESIS;

EID: 0346500693     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.10.014     Document Type: Article

References (33)

1. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.T., Sim G.A. J. Am. Chem. Soc. 88:1966;3888.
2. Werbovetz K.A., Bhattacharjee A.K., Brendle J.J., Scovill J.P. Bioorg. Med. Chem. 8:2000;1741.
3. Redinbo M.R., Stewart L., Kuhn P., Champoux J.J., Hol W.G.J. Science. 279:1998;1504.
4. Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin A.B. Jr., Stewart L. Proc. Natl. Acad. Sci. U.S.A. 99:2002;15387.
5. Wu T.-S., Chan Y.-Y., Leu Y.-L., Chern C.-Y., Chen C.-F. Phytochemistry. 42:1996;907.
6. Pendrak I., Barney S., Wittrock R., Lambert D.M., Kingsbury W.D. J. Org. Chem. 59:1994;2623.
7. Bowman W.R., Bridge C.F., Cloonan M.O., Leach D.C. Synlett. 6:2001;765.
8. Pendrak I., Barney S., Wittrock R., Lambert D.M., Kingsbury W.D. J. Org. Chem. 59:1994;2623.
9. Pendrak I., Wittrock R., Kingsbury W.D. J. Org. Chem. 60:1995;2912.
10. Perzyna A., Marty C., Facompré M., Goossens J.-F., Pommery N., Colson P., Houssier C., Houssin R., Hénichart J.-P., Bailly C. J. Med. Chem. 45:2002;5809.
11. Ma Z.-Z., Hano Y., Nomura T., Chen Y.-J. Heterocycles. 46:1997;541.
12. Ma Z.-Z., Hano Y., Nomura T., Chen Y.-J. Heterocycles. 51:1999;1593.
13. Osborne D., Stevenson P.J. Tetrahedron Lett. 43:2002;5469.
14. Mucci-LoRusso P., Polin L., Bissery M.C., Valeriote F., Plowman J.P., Luk G.D., Corbett T.H. Invest. New Drugs. 30:1989;626.
15. Meegalla S.K., Stevens G.J., McQueen C.A., Chen A.Y., Yu C., Liu L.F., Barrows L.R., LaVoie E.J. J. Med. Chem. 37:1994;3434.
16. Fry D.W., Kraker A.J., McMichael A., Ambroso L.A., Nelson J.M., Leopold W.R., Connors R.W., Bridges A.J. Science. 265:1994;1093.
17. Bencteux E., Houssin R., Hénichart J.-P. J. Heterocycl. Chem. 34:1997;1375.
18. Bouey-Bencteux E., Loison C., Pommery N., Houssin R., Hénichart J.-P. Anti-Cancer Drug Des. 13:1998;893.
19. Goossens J.-F., Bouey-Bencteux E., Houssin R., Hénichart J.-P., Colson P., Houssier C., Laine W., Baldeyrou B., Bailly C. Biochemistry. 40:2001;4663.
20. Chackal S., Houssin R., Hénichart J.-P. J. Org. Chem. 67:2002;3502.
21. Pommery, N. Personal communication.
22. Kohlhagen G., Paull K., Cushman M., Nagafuji P., Pommier Y. Mol. Pharmacol. 55:1998;50.
23. Cushman M., Jayaraman M., Vroman J.A., Fukunaga A.K., Fox B.M., Kohlhagen G., Strumberg D., Pommier Y. J. Med. Chem. 43:2000;3688.
24. Wang H.K., Morris-Natschke S.L., Lee K.H. Med. Res. Rev. 17:1997;367.
25. Hennequin L.F., Thomas A.P., Johnstone G., Stokes E.S.E., Ple P.A., Lohmann J.J.M., Ogilvie D.J., Dukes M., Wedge S.R., Curwen F.O., Kendrew J., Lambert-Van Der Brempt C. J. Med. Chem. 42:1999;5369.
26. Teague S.J. Tetrahedron Lett. 37:1996;5751.
27. Hudiicky M. J. Chem. Ed. 54:1977;100.
28. LaVoie, E. J.; Liu, L. F.; Makhey, D. PCT Int. Appl. 19,980,326, 1998; Chem. Abstr. 1998, 128, 243964.
29. Lankin D.C., Zimmer H. J. Heterocycl. Chem. 9:1972;1133.
30. Lankin D.C., Zimmer H. J. Heterocycl. Chem. 10:1973;1035.
31. Nicholas A.W., Wani M.C., Manikumar G., Wall M.E., Kohn K.W., Pommier Y. J. Med. Chem. 33:1990;972. note 8.
32. Fatmi A.A., Vaidya N.A., Iturrian W.B., De Witt Blanton C. J. Med. Chem. 27:1984;772.
33. Phillips S.D., Castle R.N. J. Heterocycl. Chem. 17:1980;1489.